Expertise in
2
conditions

John N. Staffurth

Cardiff, WLS, GB 
Expertise in
2
conditions
Cardiff, WLS, GB 

Overview

John Staffurth practices practicing medicine in Cardiff, United Kingdom.

Mr. Staffurth is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Esophageal Cancer, Bile Acid Malabsorption, Prostatectomy, and Stent Placement.

He is actively involved in clinical research, co-authoring 131 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Cardiff, WLS, United Kingdom
Other Locations
St. Bartholomew's Hospital, And Patient And Public Representative, The Mount Vernon Cancer Centre, Cambridge, ENG, United Kingdom
Sheffield, ENG, United Kingdom
Leeds, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Conventional NSAA, LHRHA
Study Phase: Phase 3
Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
Enrollment Status: Active_not_recruiting
Publish Date: February 07, 2025
Intervention Type: Procedure, Combination product
Study Drug: Standard of Care
Study Phase: Phase 2
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2020
Intervention Type: Radiation
Study Phase: Phase 2
View 3 Less Clinical Trials

131 Total Publications

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT.
Journal: Clinical and translational radiation oncology
Published: February 04, 2026

Frequently Asked Questions about John N. Staffurth

Is John N. Staffurth a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. John N. Staffurth is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does John N. Staffurth participate in research or clinical trials?

Yes. John N. Staffurth has published 131 articles and abstracts on conditions like Prostate Cancer. You can view a list of John N. Staffurth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Staffurth's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile